Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 262

1.

Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.

Thomashow B, Crapo JD, Drummond MB, Han MK, Kalhan R, Malanga E, Malanga V, Mannino DM, Rennard S, Sciurba FC, Willard KS, Wise R, Yawn B.

Chronic Obstr Pulm Dis. 2019 Jul 24;6(3):210-220. doi: 10.15326/jcopdf.6.3.2018.0167.

2.

Comparing Patients with ZZ Versus SZ Alpha-1 Antitrypsin Deficiency: Findings from AlphaNet's Disease Management Program.

Choate R, Mannino DM, Holm KE, Sandhaus RA.

Chronic Obstr Pulm Dis. 2018 Nov 30;6(1):29-39. doi: 10.15326/jcopdf.6.1.2018.0134.

3.

National and State Estimates of COPD Morbidity and Mortality - United States, 2014-2015.

Sullivan J, Pravosud V, Mannino DM, Siegel K, Choate R, Sullivan T.

Chronic Obstr Pulm Dis. 2018 Oct 12;5(4):324-333. doi: 10.15326/jcopdf.5.4.2018.0157.

4.

Overdiagnosis of COPD in Subjects With Unobstructed Spirometry: A BOLD Analysis.

Sator L, Horner A, Studnicka M, Lamprecht B, Kaiser B, McBurnie MA, Buist AS, Gnatiuc L, Mannino DM, Janson C, Bateman ED, Burney P; BOLD Collaborative Research Group.

Chest. 2019 Aug;156(2):277-288. doi: 10.1016/j.chest.2019.01.015. Epub 2019 Jan 31.

PMID:
30711480
5.

Use of a Cross-Sectional Survey in the Adult Population to Characterize Persons at High-Risk for Chronic Obstructive Pulmonary Disease.

Pleasants RA, Heidari K, Ohar J, Donohue JF, Lugogo N, Richard CL, Kanotra S, Mannino DM, Kraft M, Liao W, Strange C.

Healthcare (Basel). 2019 Jan 18;7(1). pii: E12. doi: 10.3390/healthcare7010012.

6.

Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.

Mannino DM.

Curr Opin Pulm Med. 2019 Mar;25(2):144-149. doi: 10.1097/MCP.0000000000000549.

PMID:
30520743
7.

Genotype is associated with smoking and other key health behaviors among individuals with alpha-1 antitrypsin deficiency-associated lung disease.

Holm KE, Mannino DM, Choate R, Sandhaus RA.

Respir Med. 2018 Oct;143:48-55. doi: 10.1016/j.rmed.2018.08.016. Epub 2018 Sep 1.

PMID:
30261992
8.

Impact of donor lung pathogenic bacteria on patient outcomes in the immediate post-transplant period.

Ahmad O, Shafii AE, Mannino DM, Choate R, Baz MA.

Transpl Infect Dis. 2018 Dec;20(6):e12986. doi: 10.1111/tid.12986. Epub 2018 Sep 21.

PMID:
30171789
9.

Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?

Leidy NK, Martinez FJ, Malley KG, Mannino DM, Han MK, Bacci ED, Brown RW, Houfek JF, Labaki WW, Make BJ, Meldrum CA, Quezada W, Rennard S, Thomashow B, Yawn BP.

Int J Chron Obstruct Pulmon Dis. 2018 Jun 13;13:1901-1912. doi: 10.2147/COPD.S152226. eCollection 2018.

10.

COPD at work: exposures are different than in the past, but still matter.

Heederik D, Mannino DM.

Thorax. 2018 Nov;73(11):997-998. doi: 10.1136/thoraxjnl-2018-211661. Epub 2018 Jun 19. No abstract available.

PMID:
29921700
11.

Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.

Mannino DM, Clerisme-Beaty EM, Franceschina J, Ting N, Leidy NK.

Int J Chron Obstruct Pulmon Dis. 2018 May 10;13:1515-1525. doi: 10.2147/COPD.S149669. eCollection 2018.

12.

Respiratory Symptoms in Young Adults and Future Lung Disease. The CARDIA Lung Study.

Kalhan R, Dransfield MT, Colangelo LA, Cuttica MJ, Jacobs DR Jr, Thyagarajan B, Estepar RSJ, Harmouche R, Onieva JO, Ash SY, Okajima Y, Iribarren C, Sidney S, Lewis CE, Mannino DM, Liu K, Smith LJ, Washko GR.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1616-1624. doi: 10.1164/rccm.201710-2108OC.

PMID:
29369684
13.

Occupational Noise Exposure, Bilateral High-Frequency Hearing Loss, and Blood Pressure.

Gan WQ, Mannino DM.

J Occup Environ Med. 2018 May;60(5):462-468. doi: 10.1097/JOM.0000000000001232.

PMID:
29135833
14.

Using Big Data to Reveal Chronic Respiratory Disease Mortality Patterns and Identify Potential Public Health Interventions.

Mannino DM, Sanderson WT.

JAMA. 2017 Sep 26;318(12):1112-1114. doi: 10.1001/jama.2017.11746. No abstract available.

PMID:
28973597
15.

The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.

Yawn BB, Thomashaw B, Mannino DM, Han MK, Kalhan R, Rennard S, Cerrata S, Crapo JD, Wise R.

Chronic Obstr Pulm Dis. 2017 Jul 15;4(3):177-185. doi: 10.15326/jcopdf.4.3.2017.0136. Review.

16.

Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden.

Mannino DM, Gan WO, Wurst K, Davis KJ.

Chronic Obstr Pulm Dis. 2017 Feb 3;4(2):87-96. doi: 10.15326/jcopdf.4.2.2016.0159.

17.

Benefits Among Patients with Alpha-1 Antitrypsin Deficiency Enrolled in a Disease Management and Prevention Program.

Perkins JT, Choate R, Mannino DM, Browning SR, Sandhaus RA.

Chronic Obstr Pulm Dis. 2016 Dec 24;4(1):56-64. doi: 10.15326/jcopdf.4.1.2016.0161.

18.

Exactly what is restrictive spirometry capturing?

Mannino DM.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):956. doi: 10.5588/ijtld.17.0422. No abstract available.

PMID:
28826443
19.

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations.

Accortt NA, Chung JB, Bonafede M, Limone BL, Mannino DM.

Int J Chron Obstruct Pulmon Dis. 2017 Jul 19;12:2085-2094. doi: 10.2147/COPD.S127815. eCollection 2017.

20.

Reply to Londhe et al.: CAPTURE: A Screening Tool for Chronic Obstructive Pulmonary Disease or Obstructive Airway Disease?

Martinez FJ, Han M, Leidy N, Make B, Mannino DM, Rennard SI, Thomashow BM, Yawn BP; High-Risk-COPD Screening Study Group.

Am J Respir Crit Care Med. 2018 Jan 15;197(2):272-274. doi: 10.1164/rccm.201707-1393LE. No abstract available.

21.

Different types of housing and respiratory health outcomes.

Gan WQ, Sanderson WT, Browning SR, Mannino DM.

Prev Med Rep. 2017 Jun 8;7:124-129. doi: 10.1016/j.pmedr.2017.05.018. eCollection 2017 Sep.

22.

How Well Does CAPTURE Translate?: An Exploratory Analysis of a COPD Case-Finding Method for Spanish-Speaking Patients.

Quezada WA, Whippo BA, Jellen PA, Leidy NK, Mannino DM, Kim KJ, Han MK, Houfek JF, Make B, Malley KG, Meldrum CA, Rennard SI, Yawn BP, Martinez FJ, Thomashow BM; High-Risk-COPD Screening Study Group(∗).

Chest. 2017 Oct;152(4):761-770. doi: 10.1016/j.chest.2017.03.047. Epub 2017 Apr 14.

23.

Association between Cardiorespiratory Fitness and Lung Health from Young Adulthood to Middle Age.

Benck LR, Cuttica MJ, Colangelo LA, Sidney S, Dransfield MT, Mannino DM, Jacobs DR Jr, Lewis CE, Zhu N, Washko GR, Liu K, Carnethon MR, Kalhan R.

Am J Respir Crit Care Med. 2017 May 1;195(9):1236-1243. doi: 10.1164/rccm.201610-2089OC.

24.

Defining and targeting health disparities in chronic obstructive pulmonary disease.

Pleasants RA, Riley IL, Mannino DM.

Int J Chron Obstruct Pulmon Dis. 2016 Oct 4;11:2475-2496. eCollection 2016. Review.

25.

Factors that impact medical student and house-staff career interest in brain related specialties.

Kamour AH, Han DY, Mannino DM, Hessler AB, Kedar S.

J Neurol Sci. 2016 Oct 15;369:312-317. doi: 10.1016/j.jns.2016.08.046. Epub 2016 Aug 24.

PMID:
27653916
26.

Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.

Ke X, Marvel J, Yu TC, Wertz D, Geremakis C, Wang L, Stephenson JJ, Mannino DM.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 27;11:1689-703. doi: 10.2147/COPD.S108967. eCollection 2016.

27.

Does Undiagnosed Chronic Obstructive Pulmonary Disease Matter?

Mannino DM.

Am J Respir Crit Care Med. 2016 Aug 1;194(3):250-2. doi: 10.1164/rccm.201602-0295ED. No abstract available.

PMID:
27479056
28.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, Wechsler ME.

Eur Respir J. 2016 Sep;48(3):664-73. doi: 10.1183/13993003.00436-2016. Epub 2016 Jun 23.

29.

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey.

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK.

Int J Chron Obstruct Pulmon Dis. 2016 Apr 27;11:881-90. doi: 10.2147/COPD.S102280. eCollection 2016. Erratum in: Int J Chron Obstruct Pulmon Dis. 2017 Mar 15;12 :859.

30.

Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective.

Han MK, Martinez CH, Au DH, Bourbeau J, Boyd CM, Branson R, Criner GJ, Kalhan R, Kallstrom TJ, King A, Krishnan JA, Lareau SC, Lee TA, Lindell K, Mannino DM, Martinez FJ, Meldrum C, Press VG, Thomashow B, Tycon L, Sullivan JL, Walsh J, Wilson KC, Wright J, Yawn B, Zueger PM, Bhatt SP, Dransfield MT.

Lancet Respir Med. 2016 Jun;4(6):473-526. doi: 10.1016/S2213-2600(16)00094-1. Epub 2016 May 13. Review.

PMID:
27185520
31.

Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.

Foo J, Landis SH, Maskell J, Oh YM, van der Molen T, Han MK, Mannino DM, Ichinose M, Punekar Y.

PLoS One. 2016 Apr 19;11(4):e0152618. doi: 10.1371/journal.pone.0152618. eCollection 2016.

32.

Gender and asthma-chronic obstructive pulmonary disease overlap syndrome.

Wheaton AG, Pleasants RA, Croft JB, Ohar JA, Heidari K, Mannino DM, Liu Y, Strange C.

J Asthma. 2016 Sep;53(7):720-31. doi: 10.3109/02770903.2016.1154072. Epub 2016 Apr 6.

33.

Development of a spirometry T-score in the general population.

Lee SW, Kim HK, Baek S, Jung JY, Kim YS, Lee JS, Lee SD, Mannino DM, Oh YM.

Int J Chron Obstruct Pulmon Dis. 2016 Feb 23;11:369-79. doi: 10.2147/COPD.S96117. eCollection 2016.

34.

Insight into Best Variables for COPD Case Identification: A Random Forests Analysis.

Leidy NK, Malley KG, Steenrod AW, Mannino DM, Make BJ, Bowler RP, Thomashow BM, Barr RG, Rennard SI, Houfek JF, Yawn BP, Han MK, Meldrum CA, Bacci ED, Walsh JW, Martinez F.

Chronic Obstr Pulm Dis. 2016;3(1):406-418.

35.

The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys.

Hanson C, Lyden E, Rennard S, Mannino DM, Rutten EP, Hopkins R, Young R.

Ann Am Thorac Soc. 2016 May;13(5):643-50. doi: 10.1513/AnnalsATS.201509-609OC.

PMID:
26783997
36.

Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium.

Miller BE, Tal-Singer R, Rennard SI, Furtwaengler A, Leidy N, Lowings M, Martin UJ, Martin TR, Merrill DD, Snyder J, Walsh J, Mannino DM.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):607-13. doi: 10.1164/rccm.201509-1722PP. Review.

PMID:
26745765
37.

Is it time to move beyond the "O" in early COPD?

Mannino DM, Make BJ.

Eur Respir J. 2015 Dec;46(6):1535-7. doi: 10.1183/13993003.01436-2015. No abstract available.

38.

Smoking and Emphysema: Looking Beyond the Cigarette.

Mannino DM.

Chest. 2015 Nov;148(5):1126-1127. doi: 10.1378/chest.15-1454. No abstract available.

PMID:
26527435
39.

Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality.

Martinez CH, Mannino DM, Jaimes FA, Curtis JL, Han MK, Hansel NN, Diaz AA.

Ann Am Thorac Soc. 2015 Dec;12(12):1788-95. doi: 10.1513/AnnalsATS.201506-388OC.

40.

Exposure to loud noise, bilateral high-frequency hearing loss and coronary heart disease.

Gan WQ, Moline J, Kim H, Mannino DM.

Occup Environ Med. 2016 Jan;73(1):34-41. doi: 10.1136/oemed-2014-102778. Epub 2015 Sep 15.

PMID:
26374778
41.

Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance.

Pleasants RA, Heidari K, Wheaton AG, Ohar JA, Strange C, Croft JB, Liao W, Mannino DM, Kraft M.

COPD. 2015;12(6):680-9. doi: 10.3109/15412555.2015.1043424. Epub 2015 Sep 14.

42.

Lung function impairment in the never-smoker: the search for answers continues.

Mannino DM.

Int J Tuberc Lung Dis. 2015 Sep;19(9):1001. doi: 10.5588/ijtld.15.0595. No abstract available.

PMID:
26260814
43.

Epidemiology of Chronic Obstructive Pulmonary Disease: Prevalence, Morbidity, Mortality, and Risk Factors.

Rosenberg SR, Kalhan R, Mannino DM.

Semin Respir Crit Care Med. 2015 Aug;36(4):457-69. doi: 10.1055/s-0035-1555607. Epub 2015 Aug 3. Review.

PMID:
26238634
44.

Identifying Patients with Undiagnosed COPD in Primary Care Settings: Insight from Screening Tools and Epidemiologic Studies.

Han MK, Steenrod AW, Bacci ED, Leidy NK, Mannino DM, Thomashow BM, Barr RG, Make BJ, Bowler RP, Rennard SI, Houfek JF, Yawn BP, Meldrum CA, Walsh JW, Martinez FJ.

Chronic Obstr Pulm Dis. 2015;2(2):103-121.

45.

Smoking duration, respiratory symptoms, and COPD in adults aged ≥45 years with a smoking history.

Liu Y, Pleasants RA, Croft JB, Wheaton AG, Heidari K, Malarcher AM, Ohar JA, Kraft M, Mannino DM, Strange C.

Int J Chron Obstruct Pulmon Dis. 2015 Jul 21;10:1409-16. doi: 10.2147/COPD.S82259. eCollection 2015.

46.

Clinical and Radiologic Disease in Smokers With Normal Spirometry.

Regan EA, Lynch DA, Curran-Everett D, Curtis JL, Austin JH, Grenier PA, Kauczor HU, Bailey WC, DeMeo DL, Casaburi RH, Friedman P, Van Beek EJ, Hokanson JE, Bowler RP, Beaty TH, Washko GR, Han MK, Kim V, Kim SS, Yagihashi K, Washington L, McEvoy CE, Tanner C, Mannino DM, Make BJ, Silverman EK, Crapo JD; Genetic Epidemiology of COPD (COPDGene) Investigators.

JAMA Intern Med. 2015 Sep;175(9):1539-49. doi: 10.1001/jamainternmed.2015.2735. Erratum in: JAMA Intern Med. 2015 Sep;175(9):1588.

47.

Effects of GOLD-Adherent Prescribing on COPD Symptom Burden, Exacerbations, and Health Care Utilization in a Real-World Setting.

Mannino DM, Yu TC, Zhou H, Higuchi K.

Chronic Obstr Pulm Dis. 2015 Jun 19;2(3):223-235. doi: 10.15326/jcopdf.2.3.2014.0151.

48.

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin DP, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL; ATS/ERS Task Force for COPD Research.

Eur Respir Rev. 2015 Jun;24(136):159-72. doi: 10.1183/16000617.00000315. Review.

49.

Identifying cases of undiagnosed, clinically significant COPD in primary care: qualitative insight from patients in the target population.

Leidy NK, Kim K, Bacci ED, Yawn BP, Mannino DM, Thomashow BM, Barr RG, Rennard SI, Houfek JF, Han MK, Meldrum CA, Make BJ, Bowler RP, Steenrod AW, Murray LT, Walsh JW, Martinez F; High-Risk-COPD Screening Study Group.

NPJ Prim Care Respir Med. 2015 Apr 16;25:15024. doi: 10.1038/npjpcrm.2015.24.

50.

Body mass index, respiratory conditions, asthma, and chronic obstructive pulmonary disease.

Liu Y, Pleasants RA, Croft JB, Lugogo N, Ohar J, Heidari K, Strange C, Wheaton AG, Mannino DM, Kraft M.

Respir Med. 2015 Jul;109(7):851-9. doi: 10.1016/j.rmed.2015.05.006. Epub 2015 May 16.

Supplemental Content

Loading ...
Support Center